Cost-effectiveness analysis is a mandatory strategy for health systems: evidence from a study involving therapies for hepatitis C

• Main Authors: João Paulo Vilela Rodrigues (Author), Maurílio de Souza Cazarim (Author), Silvana Gama Florencio Chachá (Author), Ana de Lourdes Candolo Martinelli (Author), Leonardo Régis Leira Pereira (Author)
• Format: Book
• Published: Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz.
• Subjects: article
• Online Access: Connect to this object online.

Abstract: Cost-effectiveness analysis is essential in health decision making. Several countries use it as synthesis of evidence to incorporate health technologies. The protease inhibitors (PI) boceprevir (BOC) and telaprevir (TVR) are indicated for chronic hepatitis C treatment and were incorporated...